Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Peripartum Cardiomyopathy, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Jeremy Pollock is a Cardiologist in Towson, Maryland. Dr. Pollock is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Atrial Fibrillation, Heart Attack, and Apoplexy.

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program. Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School’s Beth Israel Hospital, Dr. Post received her master’s degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital. Dr. Post joined the Johns Hopkins faculty in 1997. Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Post also leads Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-studies. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years. Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation. She has over 350 peer-reviewed research publications. Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty. She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow. She was co-chair of the Johns Hopkins University Committee on the Biomedical Scientific Workforce. Dr. Post is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Atherosclerosis, Coronary Heart Disease, Carotid Artery Disease, Hormone Replacement Therapy (HRT), and Aortic Valve Replacement.

Sabra Lewsey is a cardiologist specializing in heart failure in Baltimore, Maryland. Additionally, she is an assistant professor at the Baltimore-based Johns Hopkins University School of Medicine. Dr. Lewsey earned her medical degree from Columbia University College of Physicians & Surgeons and a master of public health degree from Harvard School of Public Health. She completed her residency in internal medicine at The Johns Hopkins Hospital, where she also completed fellowships in cardiology and advanced heart failure and transplant cardiology. Dr. Lewsey is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, and Heart Transplant.

Virginia Shalkey Hahn, M.D., is a cardiologist specialized in caring for patients with cardiomyopathy and heart failure. Dr. Hahn received her medical degree from the Perelman School of Medicine at the University of Pennsylvania in 2012. She was a Sarnoff Fellow at Johns Hopkins University School of Medicine. She completed internal medicine residency at the Hospital of the University of Pennsylvania and cardiology/advanced heart failure fellowship at Johns Hopkins Hospital, where she was the Marie-Josée and Henry R Kravis Chief Cardiology Fellow. Dr. Hahn's research is focused on translational studies in heart failure using bioinformatics tools and functional assays. She has won several awards and grants for her research. Dr. Hahn is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Heart Attack, and Apoplexy.

Yusra Azmi is a primary care provider, practicing in Internal Medicine in Timonium, Maryland. Dr. Azmi is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Edema, Heart Failure, and Hypertension. Dr. Azmi is currently accepting new patients.

Qinglin Gao is a primary care provider, practicing in Internal Medicine in Timonium, Maryland. Dr. Gao is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Pleurisy, Atypical Pneumonia, Hospital-Acquired Pneumonia, Endoscopy, and Gastrostomy.

Kimberly Cuomo, CRNP is a nurse practitioner in Baltimore, Maryland. She specializes in managing patients diagnosed with heart failure at the Johns Hopkins Heart Failure Bridge Clinic and heart transplant recipients. Her expertise includes cardiovascular disease assessment and managing patients diagnosed with heart failure and heart transplant recipients. Research Summary Kimberly Cuomo's research consists of managing and improving outcomes for patients diagnosed with heart failure, cardiovascular disease and heart transplant recipients. Selected Publications K. Cuomo, G. Koy, D. Fenner, S. Gulati. Use of a heart failure device diagnostics coordinator. Heart & Lung: The Journal of Acute and Critical Care , Volume 41 , Issue 4 , 423 - 424 D. Harris, D. Fenner, S. Gulati, K. Cuomo. Use of an inpatient nurse navigator to coordinate care for heart failure patients. Heart & Lung: The Journal of Acute and Critical Care, Volume 41 , Issue 4 , 422 - 423 Cuomo, K. Almansa, J. Cummings, A. Russell, S. Nurse Practitioner Run Heart Failure Bridge Clinic Reduces Readmissions. Accepted for presentation at HFSA Annual Meeting, 2015. Ms. Cuomo is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top area of expertise is Heart Failure with Preserved Ejection Fraction (HFpEF).

Dr. Jennifer Tanio is a cardiologist at the Johns Hopkins Health Care and Surgery Center at Green Spring Station. Dr. Tanio received her B.A. from Johns Hopkins University and her M.D. from the University of Pennsylvania School of Medicine. She completed her residency at the University of Pennsylvania and pursued cardiology fellowships at the University of Pennsylvania and the Johns Hopkins University School of Medicine. Dr. Tanio worked in private practice before joining the Johns Hopkins cardiology faculty. Dr. Tanio’s clinical expertise includes preventive cardiology and heart disease. Dr. Tanio is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Mitral Valve Prolapse, Heart Attack, Atherosclerosis, and Coronary Heart Disease.

Dr. Howard Steiner is an instructor of medicine at the Johns Hopkins School of Medicine. He has been practicing pulmonary and sleep consultative medicine since 1989. In his role as a diagnostician, he guides the evaluation and management of respiratory problems including infectious, malignant, allergic, autoimmune, and sleep-related disorders. He has been part-time faculty in the Johns Hopkins Pulmonary Division since 1991, is a Fellow in the American College of Chest Physicians, and mentors medical students, residents, and pulmonary fellows training at the Johns Hopkins Hospital. Contact for Research Inquiries 10755 Falls Road Pavilion I, Suite 200 Lutherville, MD 21093 Phone: (410) 583-7124 Selected Publications Lwebuga-Mukasa JS, Steiner H. Monoclonal antibody to rat lung Maclura Pomifera agglutinin (MPA) lectin binding glycoprotein localizes apically on rat and human type II pneumocytes and Clara cells. J Cell Biol 107:71a, 1989. Roberts PJ, McBean GJ, Steiner H, Kohler C, Schwarcz R. Lesioning Effects of Ibotenate in the immature rat brain and protection by 2-amino-7 phosphonoheptanoic acid. Soc Neurosci Abst 9:261, 1983. Steiner H, Ingbar DI. Mechanisms of lung injury and repair. In: Matthay RA, Matthay MA, Wiedemann HP eds. Annual Review of Pulmonary and Critical Care Medicine. Hanley & Belfus (Philadelphia, 1989), pp 205-223. Steiner H, Lwebuga-Mukasa JS. A549 cells display distinct functional and morphologic properties depending on their culture substratum. J Cell Biol 107:71a, 1989. Steiner H, Lwebuga-Mukasa JS. A549 cells produce a factor which is Mitogenic for human lung fibroblasts. Amer Rev Resp Dis 139:A492 1989. Steiner H, McBean GJ, Kohler C, Roberts PJ, Schwarcz R. Ibotenate Induced neuronal degeneration in immature rat brain. Brain Research 307:117-124, 1984. Dr. Steiner is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Bronchiectasis, Obstructive Sleep Apnea, Lung Metastases, and Interstitial Lung Disease.

Dr. Seamus Whelton MD, MPH, is an Associate Professor of Cardiology and member of the Ciccarone Center for the Prevention of Cardiovascular Disease. His primary clinical and research expertise includes the pathogenesis, risk prediction, prevention, and treatment of atherosclerotic cardiovascular disease with an emphasis on the identification of coronary artery calcium via cardiac CT scanning. He is Director of the Advanced Subclinical Atherosclerosis Clinic, which focuses on the treatment of patients with incidentally discovered coronary artery calcium detected by CT imaging. He is also an expert on the pathogenesis, epidemiology, and risk factors for aortic valve calcification. He has led pioneering research to describe the use aortic valve calcification to predict the risk of aortic stenosis. Dr. Whelton has published more than 130 peer reviewed manuscripts, multiple book chapters, and has been an invited lecturer at both national and international conferences. He is an Associate Editor at the Journal of Cardiovascular Computed Tomography and the American Journal of Preventive Cardiology. He is a member of the American College of Cardiology Prevention of Cardiovascular Disease Leadership Council. He has been the Principal Investigator on grants from the National Institutes of Health and American Heart Association. Dr. Whelton received his undergraduate degree at Princeton University. He then completed a Masters of Public Health in Epidemiology at the Tulane University School of Public Health and Tropical Medicine followed by his Doctor of Medicine degree from the Tulane University School of Medicine. He subsequently completed a post-doctoral fellowship at the Welch Center for Prevention, Epidemiology and Clinical Research at the Johns Hopkins Bloomberg School of Public Health and then completed a fellowship in Cardiology at the Johns Hopkins School of Medicine before joining the Cardiology Faculty at Johns Hopkins in 2017. Videos Dr. Seamus Whelton. Dr. Whelton is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Atherosclerosis, Apoplexy, Coronary Heart Disease, Pacemaker Implantation, and Heart Bypass Surgery.

Tala K Al-Talib, M.D. is a cardiologist in Baltimore, MD. She is the Medical Director of Johns Hopkins Medicine – Cardiology at Johns Hopkins Greenspring Station. Dr. Al-Talib’s clinical areas of focus are in general and preventative cardiology. She specializes in cardiovascular disease in women, with a particular interest in cardiovascular risk assessment and treatment of cardiac conditions in women with breast cancer or other oncological history. She was integral in the establishment of the Preventative Cardiology Program to Improve Heart Health for Female Breast Cancer Survivors, a collaborative effort to detect asymptomatic cardiovascular disease and ultimately prevent cardiovascular events in this patient group. After receiving her medical degree from University of Maryland School of Medicine, Dr. Al-Talib completed her residency in Internal Medicine at the University of Maryland Medical Center, where she was Chief Medical Resident. She completed her post-doctoral fellowship in cardiovascular medicine at University of Maryland Medical Center. In addition to her clinical practice, Dr. Al-Talib also serves as an inpatient echocardiographer at Bayview Medical Center, performing transesophageal echo (TEE) and cardioversions and attends on the inpatient cardiology services. Videos Red Chair SeriesDr. Tala Al-Talib. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Heart Attack, Cardiomyopathy Due to Anthracyclines, Doxorubicin-Induced Cardiomyopathy, and Apoplexy.

Ahmet Kilic is a cardiac surgeon in Baltimore, Maryland. He is an associate professor of surgery at the Baltimore-based Johns Hopkins University School of Medicine. He also serves as director of heart transplantation and mechanical circulatory support. Dr. Kilic's areas of clinical expertise include adult cardiac surgery with a special interest in heart transplantation and mechanical circulatory support. Prior to joining Johns Hopkins, Dr. Kilic served as associate professor of surgery at The Ohio State University Wexner Medical Center and was the director of the heart transplant and mechanical circulatory support programs. He was co-director of the advanced heart failure program as well as the vice director of clinical and academic affairs in the division of cardiac surgery. Although a recognized leader in the field of heart failure, Dr. Kilic’s expertise runs the spectrum of cardiac surgery. Dr. Kilic is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Tumor, Restrictive Cardiomyopathy (RCM), Supravalvular Aortic Stenosis, Heart Transplant, and Heart Bypass Surgery.

Stacey Schott, M.D., M.P.H., is a preventive cardiologist and an assistant professor in the cardiovascular division at the Johns Hopkins University School of Medicine. She specializes in preventive cardiology, cardiovascular disease, heart disease, echocardiography and nuclear cardiology. Dr. Schott is a member of the Academy of Communication in Healthcare, an organization committed to improving relationship-centered health care communication. She is also a member of The American Society for Preventive Cardiology and the American College of Preventive Medicine. Dr. Schott’s research focuses on preventive cardiology, cardiovascular disease and health care communication. Dr. Schott is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Heart Failure, Heart Attack, Apoplexy, and Inappropriate Sinus Tachycardia (IST).

Anoop Patel is a Cardiologist in Towson,, Maryland. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Pulmonary Edema, Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), and Atherosclerosis.

Ronald Schechter is a Cardiologist in Towson, Maryland. Dr. Schechter is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Cardiomyopathy, Necrosis, Atherosclerosis, and Coronary Heart Disease.

Dr. Adamo is a physician-scientist and the director for Cardiac Immunology in the Johns Hopkins University Division of Cardiology. Born and raised in the south of Italy, after completing medical school, Dr. Adamo moved to the U.S. to pursue a Ph.D. in Biology and Biomedical Sciences at Harvard Medical School. He then went to Washington University School of Medicine where he completed post-graduate training in internal medicine, cardiovascular disease, and advanced heart failure/cardiac transplant. He finally returned to basic science to complete post-doctoral training in cardiac immunology. Dr. Adamo is involved in both basic research and clinical research. His basic research focuses on the relationship between the immune system and the heart, in health and disease. His clinical research has focused on heart failure with normalized ejection fraction and patient selection for mechanical circulatory support. A father of 5, Dr. Adamo has a passion for entrepreneurship and has been involved with the launch of 3 start-up companies. He holds a weekly clinic and attends on the inpatient heart failure service within the Hopkins system. Dr. Adamo is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Peripartum Cardiomyopathy, Cardiomyopathy, Heart Failure, and Myocarditis.

Dr. Reed David Riley is an assistant professor of medicine at the Johns Hopkins University School of Medicine and chief of cardiology at the Greater Baltimore Medical Center. Dr. Riley received his undergraduate degree from Duke University. He earned a medical degree from The Johns Hopkins University School of Medicine and completed a residency at Johns Hopkins Hospital. Prior to joining Johns Hopkins in 2007, Dr. Riley was a cardiology fellow at Duke University and staff cardiologist at Sinai Hospital of Baltimore. He is currently also a teaching attending on the Osler Medical Service’s Barker Firm at the Johns Hopkins Hospital. Dr. Riley is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Attack, Atrial Fibrillation, Apoplexy, and Angina.